Found 7 matching trials
A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)
PHASE2Primary objective:
To evaluate the overall response rate of tegafur/uracil...
Location
Far Eastern Memorial Hospital
Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve
PHASE3To compare the overall survival of thalidomide- and placebo-treated advance...
Location
Taiwan Cooperative Oncology Group
Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)
PHASE1The purpose of this phase I study is to determine the maximal tolerable dos...
Location
Ghang-Gung Memorial Hospital at Chia-Yi
An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer
PHASE2Trial objectives: The primary objective is to determine the proportion of p...
Location
Mackay Memorial Hospital
Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
PHASE2This single-centered phase II clinical study is to obtain preliminary infor...
Location
Chang Gung Memorial Hospital
UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma
PHASE2We hypothesize that combination of tegafur/uracil(UFUR) and thalidomide, bo...
Location
Department of Oncology , National Taiwan University Hospital
Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
PHASE2The purpose of this study is to determine whether lower than conventional d...
Location
Tata Memorial Hospital